The Brigham and Women's Hospital Addiction Medicine Fellowship is a one-year, Accreditation Council for Graduate Medical Education (ACGME)-accredited fellowship program in addiction medicine, open to physicians who have completed any ACGME-accredited residency program. Our goal is to train the next generation of leaders in the prevention, diagnosis, assessment, treatment and recovery of those individuals with substance use disorders and related medical and psychiatric co-morbidities. The program is designed to prepare fellows for a variety of academic and clinical opportunities related to substance use disorders. Fellows completing the program will qualify to sit for the addiction medicine board exam from the American Board of Preventive Medicine.
We provide cutting-edge training in the treatment of substance use disorders that span the entire spectrum of treatment levels, including medically-supervised withdrawal (detoxification), inpatient addiction consultation-liaison, low-barrier and low-threshold model (Bridge Clinic), specialty addiction outpatient and partial hospital program, as well as opportunities to treat patients at the Boston Health Care for the Homeless, methadone clinic, Section 35 facility, and adolescents at Boston Children’s Hospital. Fellows will also learn from pain specialists and medical toxicologists who practice at the intersection of addiction medicine in outpatient and emergency room settings, respectively. Finally, fellows will have opportunities for scholarly activity and research collaborations.
The academic year starts with a two-week long “Addiction Boot Camp” to help orient all of our fellows, followed by weekly didactics, fellows meeting and monthly journal clubs. A unique aspect of the Brigham program is that we provide fellows with an opportunity to gain skills in the treatment of patients with substance use disorders who have co-morbid psychiatric disorders as well as serious infectious complications related to their substance use. Fellows will gain experience by working with staff psychiatrists, collaborating with infectious disease specialists during both inpatient consult-liaison and Bridge Clinic rotations. In addition, fellows will be encouraged to work with addiction specialists to participate in scholarly projects, present at national conferences, and become well versed in the practice of motivational interviewing.
Clinical Training Sites and Experience
Addiction medicine fellows will divide their time between the inpatient and outpatient settings. The year will be divided into rotations that are two weeks in duration. The distribution of rotations is:
Addiction Bootcamp (two-week orientation to all clinical sites and didactics on core addiction medicine topics)
Inpatient addiction consults at Brigham and Women’s Hospital (18 weeks)
Personal statement describing your interests, achievements and career goals
Three letters of recommendation, one coming from your program director
United States Medical Licensing Examination (USMLE) scores
Other documents per ERAS
Timeline: Interviews will be given on a rolling basis. Applications sent before August 1, 2020 will be given priority. Once a completed application has been submitted it will be reviewed. Interviews will take place in the fall.
Eligibility: Applicants must have completed or plan to complete an ACGME-accredited anesthesiology, emergency medicine, family medicine, internal medicine, obstetrics and gynecology, pediatrics, preventive medicine, or psychiatry residency prior to the start of fellowship. A full Massachusetts medical license is required before starting the fellowship as well as a physician waiver to prescribe buprenorphine.
Please note: We strongly advise that applicants begin the application process for the full licensure in the state of Massachusetts by January 1 of their potential training year if they anticipate moving to the state. If there are documents from previous positions or schools where you have trained that you think may be difficult to obtain, we suggest that you begin the process of obtaining them as soon as possible. Information on how to obtain the waiver can be found at the Substance Abuse and Mental Health Services Administration (SAMHSA) website.